跳至主要内容
临床试验/CTRI/2012/09/003001
CTRI/2012/09/003001已完成4 期

Double-blind, multicenter, prospective, comparative study to evaluate the efficacy and safety of 0.05% halobetasol propionate ointment and 0.05% clobetasol propionate ointment in subjects with chronic, localized plaque psoriasis

Glenmark Pharmaceuticals Limited0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • 1.Subjects between 18 to 60 yrs ( treatment naïve patients or patients receiving treatments such as Corticosteroids, Methotrexate or PUVA should be given a wash out period of 10 days)
  • 2.Clinically diagnosed localized, plaque psoriasis vulgaris or Palmoplanter psoriasis affecting maximum up to 10-20% of the total body surface area. The size of lesion selected is approximately 4 to 10 cm2
  • 3.Subjects must provide written informed consent and comply to the protocol.

排除标准

  • 1.Subjects with psoriatic erythroderma, generalized pustular psoriasis
  • 2.Pregnancy & Lactation
  • 3.Concomitant tuberculosis
  • 4.Syphilis
  • 5.Uncontrolled Diabetes mellitus
  • 6.Leukemia

研究者

相似试验

尚未招募
4 期
A Phase IV study to evaluate safety and efficacy of Intravenous Ulinastatin versus Placebo administered along with standard supportive care
CTRI/2016/06/007046upin Limited
进行中(未招募)
1 期
Multicentre, prospective, double-blind, in parallel groups, randomized, placebo-controlled clinical trial to evaluate the short-term efficacy and safety of Betamethasone valerate 2.25 mg medicated plaster in patients with chronic lateral epicondylitis (tennis elbow)Chronic Lateral Elbow TendinopathyMedDRA version: 17.1Level: LLTClassification code 10043258Term: Tennis elbowSystem Organ Class: 100000004863MedDRA version: 17.1Level: LLTClassification code 10024032Term: Lateral epicondylitisSystem Organ Class: 100000004863
EUCTR2014-004119-35-ITIBSA Institut Biochimique SA
进行中(未招募)
不适用
Comparative, multicentre, randomised, double-blind study to assess the efficacy of tacrolimus 0.03% ointment versus fluticasone 0.005% ointment in children aged 2 years or over suffering from moderate to severe atopic dermatitisModerate to severe atopic dermatitisMedDRA version: 7.0Level: LLTClassification code 10003639
EUCTR2004-002478-47-FIFujisawa GmbH460
进行中(未招募)
不适用
Comparative, multicentre, randomised, double-blind study to assess the efficacy of tacrolimus 0.1% ointment versus fluticasone 0.005% ointment in adult patients suffering from moderate to severe atopic dermatitis and presenting with so-called red face lesions of the head and neck
EUCTR2004-002477-23-FIFujisawa GmbH510
进行中(未招募)
1 期
Comparative, multicentre, randomised, double-blind study to assess the efficacy of tacrolimus 0.1% ointment versus fluticasone 0.005% ointment in adult patients suffering from moderate to severe atopic dermatitis and presenting with so-called red face lesions of the head and neckModerate to severe atopic dermatitis and presenting with so-called red face lesions of the head and neck.MedDRA version: 7.0Level: LLTClassification code 10003639
EUCTR2004-002477-23-BEFujisawa GmbH510